|
1
|
Juergens RA and Brahmer JR: Adjuvant
treatment in non-small cell lung cancer: Where are we now? J Natl
Compr Cancer Netw. 4:595–600. 2006. View Article : Google Scholar
|
|
2
|
Xia J, Wu Z, Yu C, He W, Zheng H, He Y,
Jian W, Chen L, Zhang L and Li W: miR-124 inhibits cell
proliferation in gastric cancer through down-regulation of SPHK1. J
Pathol. 227:470–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Go MK, Zhang WC, Lim B and Yew WS: Glycine
decarboxylase is an unusual amino acid decarboxylase involved in
tumorigenesis. Biochemistry. 53:947–956. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li X, Cui C, Guo Y and Yang G: Glycine
decarboxylase expression increased in p53-mutated B cell lymphoma
mice. Oncol Res Treat. 38:586–589. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jones PA and Baylin SB: The epigenomics of
cancer. Cell. 128:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chuang JC and Jones PA: Epigenetics and
microRNAs. Pediatr Res. 61:R24–R29. 2007. View Article : Google Scholar
|
|
7
|
Fabbri M, Garzon R, Cimmino A, Liu Z,
Zanesi N, Callegari E, Liu S, Alder H, Costinean S,
Fernandez-Cymering C, et al: MicroRNA-29 family reverts aberrant
methylation in lung cancer by targeting DNA methyltransferases 3A
and 3B. Proc Natl Acad Sci USA. 104:15805–15810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Subramaniam D, Thombre R, Dhar A and Anant
S: DNA methyltransferases: A novel target for prevention and
therapy. Front Oncol. 4:802014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ren J, Singh BN, Huang Q, Li Z, Gao Y,
Mishra P, Hwa YL, Li J, Dowdy SC and Jiang SW: DNA hypermethylation
as a chemotherapy target. Cell Signal. 23:1082–1093. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jin B, Li Y and Robertson KD: DNA
methylation: Superior or subordinate in the epigenetic hierarchy?
Genes Cancer. 2:607–617. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ferguson-Smith AC and Greally JM:
Epigenetics: Perceptive enzymes. Nature. 449:148–149. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miremadi A, Oestergaard MZ, Pharoah PD and
Caldas C: Cancer genetics of epigenetic genes. Hum Mol Genet.
16:R28–R49. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Girault I, Tozlu S, Lidereau R and Bièche
I: Expression analysis of DNA methyltransferases 1, 3A, and 3B in
sporadic breast carcinomas. Clin Cancer Res. 9:4415–4422.
2003.PubMed/NCBI
|
|
14
|
Saito Y, Kanai Y, Nakagawa T, Sakamoto M,
Saito H, Ishii H and Hirohashi S: Increased protein expression of
DNA methyltransferase (DNMT) 1 is significantly correlated with the
malignant potential and poor prognosis of human hepatocellular
carcinomas. Int J Cancer. 105:527–532. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Patra SK, Patra A, Zhao H and Dahiya R:
DNA methyltransferase and demethylase in human prostate cancer. Mol
Carcinog. 33:163–171. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eads CA, Danenberg KD, Kawakami K, Saltz
LB, Danenberg PV and Laird PW: CpG island hypermethylation in human
colorectal tumors is not associated with DNA methyltransferase
overexpression. Cancer Res. 59:2302–2306. 1999.PubMed/NCBI
|
|
17
|
Belinsky SA, Nikula KJ, Palmisano WA,
Michels R, Saccomanno G, Gabrielson E, Baylin SB and Herman JG:
Aberrant methylation of p16INK4a is an early event in lung cancer
and a potential biomarker for early diagnosis. Proc Natl Acad Sci
USA. 95:11891–11896. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Soria JC, Lee HY, Lee JI, Wang L, Issa JP,
Kemp BL, Liu DD, Kurie JM, Mao L and Khuri FR: Lack of PTEN
expression in non-small cell lung cancer could be related to
promoter methylation. Clin Cancer Res. 8:1178–1184. 2002.PubMed/NCBI
|
|
19
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pasquinelli AE, Reinhart BJ, Slack F,
Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B,
Müller P, et al: Conservation of the sequence and temporal
expression of let-7 heterochronic regulatory RNA. Nature.
408:86–89. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
London SJ, Yuan JM, Chung FL, Gao YT,
Coetzee GA, Ross RK and Yu MC: Isothiocyanates, glutathione
S-transferase M1 and T1 polymorphisms, and lung-cancer risk: A
prospective study of men in Shanghai, China. Lancet. 356:724–729.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang A, Wang X, Shan X, Li Y, Wang P,
Jiang P and Feng Q: Curcumin reactivates silenced tumor suppressor
gene RARβ by reducing DNA methylation. Phytother Res. 29:1237–1245.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gehrmann M, Cervello M, Montalto G,
Cappello F, Gulino A, Knape C, Specht HM and Multhoff G: Heat shock
protein 70 serum levels differ significantly in patients with
chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
Front Immunol. 5:3072014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liao XH, Lu DL, Wang N, Liu LY, Wang Y, Li
YQ, Yan TB, Sun XG, Hu P and Zhang TC: Estrogen receptor α mediates
proliferation of breast cancer MCF-7 cells via a
p21/PCNA/E2F1-dependent pathway. FEBS J. 281:927–942. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang D, Liang T, Gu Y, Zhao Y, Shi Y, Zuo
X, Cao Q, Yang Y and Kan Q: Protein N-arginine methyltransferase 5
promotes the tumor progression and radioresistance of
nasopharyngeal carcinoma. Oncol Rep. 35:1703–1710. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kataoka J, Shiraha H, Horiguchi S,
Sawahara H, Uchida D, Nagahara T, Iwamuro M, Morimoto H, Takeuchi
Y, Kuwaki K, et al: Loss of Runt-related transcription factor 3
induces resistance to 5-fluorouracil and cisplatin in
hepatocellular carcinoma. Oncol Rep. 35:2576–2582. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiang Y, Lu DL, Li JP, Yu CX, Zheng DL,
Huang X, Wang ZY, Hu P, Liao XH and Zhang TC: Myocardin inhibits
estrogen receptor alpha-mediated proliferation of human breast
cancer MCF-7 cells via regulating MicroRNA expression. IUBMB Life.
68:477–487. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gong J, Li J, Wang Y, Liu C, Jia H, Jiang
C, Wang Y, Luo M, Zhao H, Dong L, et al: Characterization of
microRNA-29 family expression and investigation of their
mechanistic roles in gastric cancer. Carcinogenesis. 35:497–506.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu J, Ryan DG, Getsios S,
Oliveira-Fernandes M, Fatima A and Lavker RM: MicroRNA-184
antagonizes microRNA-205 to maintain SHIP2 levels in epithelia.
Proc Natl Acad Sci USA. 105:19300–19305. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peto R, Darby S, Deo H, Silcocks P,
Whitley E and Doll R: Smoking, smoking cessation, and lung cancer
in the UK since 1950: Combination of national statistics with two
case-control studies. BMJ. 321:323–329. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jeltsch A: Beyond Watson and Crick: DNA
methylation and molecular enzymology of DNA methyltransferases.
Chembiochem. 3:274–293. 2002. View Article : Google Scholar : PubMed/NCBI
|
